Drittone, D.;                     Lucci, C.;                     Esposito, L.;                     Mazzuca, F.;                     Pisegna, S.    
        Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging Treatments. Cancers 2025, 17, 3520.
    https://doi.org/10.3390/cancers17213520
    AMA Style
    
                                Drittone D,                                 Lucci C,                                 Esposito L,                                 Mazzuca F,                                 Pisegna S.        
                Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging Treatments. Cancers. 2025; 17(21):3520.
        https://doi.org/10.3390/cancers17213520
    
    Chicago/Turabian Style
    
                                Drittone, Denise,                                 Claudia Lucci,                                 Luisa Esposito,                                 Federica Mazzuca,                                 and Simona Pisegna.        
                2025. "Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging Treatments" Cancers 17, no. 21: 3520.
        https://doi.org/10.3390/cancers17213520
    
    APA Style
    
                                Drittone, D.,                                 Lucci, C.,                                 Esposito, L.,                                 Mazzuca, F.,                                 & Pisegna, S.        
        
        (2025). Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging Treatments. Cancers, 17(21), 3520.
        https://doi.org/10.3390/cancers17213520